Neumora Therapeutics, Inc.
Clinical trials sponsored by Neumora Therapeutics, Inc., explained in plain language.
-
New depression pill enters final testing phase
Symptom relief OngoingThis study tests an experimental oral drug, NMRA-335140, against a placebo in 332 adults with major depressive disorder. The goal is to see if the drug reduces depression symptoms over 6 weeks. Participants who finish may join an open-label extension study.
Phase: PHASE3 • Sponsor: Neumora Therapeutics, Inc. • Aim: Symptom relief
Last updated May 26, 2026 09:00 UTC
-
New depression pill shows promise in Large-Scale trial
Symptom relief OngoingThis study tests an experimental oral drug, NMRA-335140, against a placebo in 332 adults with major depressive disorder. Participants take the drug or placebo daily for 6 weeks to see if it reduces depression symptoms. The goal is to find a new treatment option for people with de…
Phase: PHASE3 • Sponsor: Neumora Therapeutics, Inc. • Aim: Symptom relief
Last updated May 26, 2026 08:34 UTC